Please login to the form below

PRMA Consulting Ltd

PRMA Consulting is an independent consultancy solving some of the most challenging pricing, reimbursement and market access issues facing international pharmaceutical and biotechnology companies today.

Our tailored services include strategic market access, landscape assessments, payer and KOL engagement, value propositions, GVDs, evidence generation, real-world evidence, pricing and reimbursement strategy.

Quality is at the heart of every engagement we deliver. We pride ourselves on providing pragmatic and insightful solutions that are informed and validated by a global network of over 700 advisors from 18 countries. We are an experienced, highly educated, multidisciplinary team with broad disease area backgrounds and extensive, practical market access knowledge.

Our experience encompasses a wide range of indications, including; cardiovascular and renal, gastroenterology, immunology, infectious diseases and vaccines, metabolism and endocrinology, neurology and psychiatry, oncology/hematology, ophthalmology, rare diseases, reproductive, and urology.

In collaboration with leading pharmaceutical organizations, we have developed a suite of digital applications that transform market access processes. These dynamic applications enable clients to unlock and optimize product value from early development through to successful country submissions.

“I wanted to thank you for the very thorough, high quality, and tremendously useful piece of work you have completed. There is a lot to digest. This is what I call ‘value for money’.”
Global reimbursement Director, top-20 pharmaceutical company

“The HTA submissions produced using the PRMA Navigator® saved us weeks. The robust content provided a high quality first draft and provided a more focused source than the GVD, targeted to our country-specific needs.”
Country market access manager, top-10 pharmaceutical company

Press Releases

Five new case studies describe how top-10 manufacturers have transformed their market access processes
Drive payer submission readiness for your Phase 2 and 3 products

PRMA Healthcheck® late module celebrates over 40 readiness assessments successfully delivered and announces a new version release.

White Papers and Resources

The relevance of patient perspectives to value: Patient Involvement in Health Technology Assessment
Exploring the evolution of patient involvement in health technology assessment (HTA), and the role of the patient voice in market access.
Four recommendations to kick-start the digital transformation of your market access processes

Darren McBride shares his experience of digital transformation in pharmaceutical and biotechnology market access, and makes four recommendations for those who are keen to drive change.

Digital applications are transforming the market access landscape

Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy.

Achieve up to 80% auto-population of your first draft HTA submission

Videos

Latest Tweets

Company Details

PRMA Consulting Ltd

+44 (0)1252 786284

Contact Website

Address:
Linea House
Harvest Crescent
Ancells Business Park
Fleet
GU51 2UZ
United Kingdom

Latest content on this profile

The relevance of patient perspectives to value: Patient Involvement in Health Technology Assessment
Exploring the evolution of patient involvement in health technology assessment (HTA), and the role of the patient voice in market access.
PRMA Consulting Ltd
Four recommendations to kick-start the digital transformation of your market access processes
Darren McBride shares his experience of digital transformation in pharmaceutical and biotechnology market access, and makes four recommendations for those who are keen to drive change.
PRMA Consulting Ltd
Five new case studies describe how top-10 manufacturers have transformed their market access processes

PRMA Consulting Ltd
Transforming the market access landscape with digital applications
Pharmaceutical and biotechnology companies are turning to technology more frequently to solve business issues, and are increasingly using digital technology to optimize market access for their products.Read the article >>  https://www.prmaconsulting.com/digital_applications_whitepaper/index.html?utm_source=PMLiVE&utm_medium=HubArticle&utm_campaign=DigitalTransThis new article helps you to:appreciate why digital applications are transforming the value and access functionsunderstand how new technology is informing direction and becoming an essential enabler in realizing visiongain insight into considerations for re-evaluating your technology and your suppliers.
PRMA Consulting Ltd
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy.
PRMA Consulting Ltd
Achieve up to 80% auto-population of your first draft HTA submission

PRMA Consulting Ltd